Jump to content

User:Hammer q/Sofinicline

From Wikipedia, the free encyclopedia

Sofinicline
Clinical data
Other namesABT-894, sofinicline besylate
Routes of
administration
Oral
Identifiers
  • (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane
CAS Number
PubChem CID
PubChem SID
DrugBank
ChemSpider
UNII
KEGG
Chemical and physical data
FormulaC10H11Cl2N3
Molar mass244.12 g·mol−1
3D model (JSmol)
Density1.406 ± 0.06 g/cm3
Boiling point417.350 ± 45.00 °C (783.230 ± 81.000 °F) Predicted
Solubility in water2 g/L
  • C1[C@H]2CN(C[C@H]2N1)C3=CC(=C(N=C3)Cl)Cl
  • InChI=1S/C10H11Cl2N3/c11-8-1-7(3-14-10(8)12)15-4-6-2-13-9(6)5-15/h1,3,6,9,13H,2,4-5H2/t6-,9+/m0/s1
  • Key:MBQYQLWSBRANKQ-IMTBSYHQSA-N

Sofinicline is an investigational non-stimulant drug for the treatment of ADHD. It is a nicotinic acetylcholine receptor (nAChR) α4β2 agonist.[1]

References

[edit]
  1. ^ Fleisher C, McGough J (August 2014). "Sofinicline: a novel nicotinic acetylcholine receptor agonist in the treatment of attention-deficit/hyperactivity disorder". Expert Opinion on Investigational Drugs. 23 (8): 1157–1163. doi:10.1517/13543784.2014.934806. PMID 24965900.
[edit]